Control Bionics Limited

A$0.05As of Sun 8 Nov 2026, 12:00 UTC
ASX:CBLHealthcare
Country Australia
PE (Fwd) •••
TSR 6Y CAGR (38.37%)
Div yield —
ROE (122.92%)
Medical Devices
Beta (5Y) 0.15
PE TTM —
TSR TTM 44.12%
Mkt cap A$26.61M
ROIC (64.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0509
3.88%
196.97%
Hold 9|3|12|2|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
4.22%
10.49%
2.21%
14.80%
Revenue$M
2.090
2.193
2.254
2.265
1.29%
1.16%
6.98%
5.23%
Peers (US$18.28M)
Cap (US$)
PE
16.02M
—
18.22M
—
Capital
TTM
5Y
10Y
Leveragex
0.394
(0.218)
(0.185)
EBIT/Intx
2.249
0.864
0.736
Own earn%
47.72
(18.19)
(30.09)
Sh yield%
33.97
13.24
16.17
Owners
Insiders/Inst%
13.00
31.42
Short interest%
5.38
SBC / revenue%
4.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
0–3
$1 testx
−0.3
Incr. ROIC%
3